These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1969717)

  • 1. The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat.
    Khuenl-Brady K; Castagnoli KP; Canfell PC; Caldwell JE; Agoston S; Miller RD
    Anesthesiology; 1990 Apr; 72(4):669-74. PubMed ID: 1969717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, neuromuscular effects, and biodisposition of 3-desacetylvecuronium (Org 7268) in cats.
    Segredo V; Shin YS; Sharma ML; Gruenke LD; Caldwell JE; Khuenl-Brady KS; Agoston S; Miller RD
    Anesthesiology; 1991 Jun; 74(6):1052-9. PubMed ID: 1675040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and disposition of pipecuronium bromide in dogs with and without ligated renal pedicles.
    Khuenl-Brady KS; Sharma M; Chung K; Miller RD; Agoston S; Caldwell JE
    Anesthesiology; 1989 Dec; 71(6):919-22. PubMed ID: 2556065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and neuromuscular effects of three steroidal neuromuscular blocking drugs in dogs (ORG 9616, ORG 9426, ORG 9991).
    Cason B; Baker DG; Hickey RF; Miller RD; Agoston S
    Anesth Analg; 1990 Apr; 70(4):382-8. PubMed ID: 1969251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations.
    Muir AW; Houston J; Green KL; Marshall RJ; Bowman WC; Marshall IG
    Br J Anaesth; 1989 Oct; 63(4):400-10. PubMed ID: 2573387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the neuromuscular blocking and autonomic effects of two new short-acting muscle relaxants with those of succinylcholine in the anesthetized cat and pig.
    Muir AW; Houston J; Marshall RJ; Bowman WC; Marshall IG
    Anesthesiology; 1989 Mar; 70(3):533-40. PubMed ID: 2564263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of vecuronium bromide in the cat.
    Bencini AF; Scaf AH; Agoston S; Houwertjes MC; Kersten UW
    Br J Anaesth; 1985 Aug; 57(8):782-8. PubMed ID: 2861839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
    Atherton DP; Hunter JM
    Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers.
    Caldwell JE; Szenohradszky J; Segredo V; Wright PM; McLoughlin C; Sharma ML; Gruenke LD; Fisher DM; Miller RD
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1216-22. PubMed ID: 7932174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat.
    Bowman WC; Rodger IW; Houston J; Marshall RJ; McIndewar I
    Anesthesiology; 1988 Jul; 69(1):57-62. PubMed ID: 2898902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset and recovery of rocuronium (Org 9426) and vecuronium under enflurane anaesthesia.
    Mayer M; Doenicke A; Hofmann A; Peter K
    Br J Anaesth; 1992 Nov; 69(5):511-2. PubMed ID: 1361356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and disposition of pipecuronium bromide in the cat.
    Agoston S; Vandenbrom RH; Wierda JM; Houwertjes MC; Kersten UW
    Eur J Anaesthesiol; 1988 Jul; 5(4):233-42. PubMed ID: 2848702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of the aminosteroidal non-depolarizing neuromuscular blocking agents rocuronium and vecuronium in plasma with liquid chromatography-tandem mass spectroscopy.
    Gutteck-Amsler U; Rentsch KM
    Clin Chem; 2000 Sep; 46(9):1413-4. PubMed ID: 10973876
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl.
    Wierda JM; Kleef UW; Lambalk LM; Kloppenburg WD; Agoston S
    Can J Anaesth; 1991 May; 38(4 Pt 1):430-5. PubMed ID: 1829656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative pre- and postjunctional effects of a new vecuronium analogue, Org 9426, at the rat neuromuscular junction.
    Tian L; Mehta MP; Prior C; Marshall IG
    Br J Anaesth; 1992 Sep; 69(3):284-7. PubMed ID: 1356399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487.
    McCourt KC; Mirakhur RK; Lowry DW; Carroll MT; Sparr HJ
    Br J Anaesth; 1999 May; 82(5):755-6. PubMed ID: 10536556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of rocuronium bromide in hepatic cirrhosis.
    Hunter JM
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():39-41. PubMed ID: 8557004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacokinetic-dynamic relationship between rapacuronium (Org 9487) and its 3-desacetyl metabolite (Org 9488).
    Schiere S; Proost JH; Schuringa M; Wierda JM
    Anesth Analg; 1999 Mar; 88(3):640-7. PubMed ID: 10072020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.